NCT Number,Study Title,Study URL,Acronym,Study Status,Brief Summary,Study Results,Conditions,Interventions,Primary Outcome Measures,Secondary Outcome Measures,Other Outcome Measures,Sponsor,Collaborators,Sex,Age,Phases,Enrollment,Funder Type,Study Type,Study Design,Other IDs,Start Date,Primary Completion Date,Completion Date,First Posted,Results First Posted,Last Update Posted,Locations,Study Documents
NCT01689519,A Study Comparing Vemurafenib Versus Vemurafenib Plus Cobimetinib in Participants With Metastatic Melanoma,https://clinicaltrials.gov/study/NCT01689519,coBRIM,COMPLETED,"To evaluate the efficacy of vemurafenib in combination with cobimetinib (GDC-0973), compared with vemurafenib and placebo, in previously untreated BRAF V600 mutation-positive patients with unresectable locally advanced or metastatic melanoma, as measured by progression-free survival (PFS), assessed by the study site investigator.",YES,Malignant Melanoma,DRUG: Placebo|DRUG: Vemurafenib|DRUG: Cobimetinib,"Progression-free Survival, Progression-free survival was defined as the time from randomization to the first occurrence of disease progression, as determined by the investigator using Response Evaluation Criteria in Solid Tumors v1.1, or death from any cause, whichever came first. Disease progression was defined as: (1) at least a 20% increase in the sum (the increase in the sum must be at least 5 mm) of diameters of target lesions, taking as reference the smallest sum during the study; (2) unequivocal progression of existing non-target lesions; or (3) the appearance of 1 or more new lesions., Baseline to the 21 July 2019 data cut-off (up to 7 years, 6 months)","Overall Survival, Overall survival was defined as the time from randomization until the date of death from any cause., Baseline to the 21 July 2019 data cut-off (up to 7 years, 6 months)|Percentage of Participants With an Objective Response, An objective response was defined as a complete response or a partial response determined on two consecutive occasions ≥ 4 weeks apart. Responses were determined by Response Evaluation Criteria in Solid Tumors v1.1. A complete response was defined as the disappearance of all target lesions or the disappearance of all non-target lesions and normalization of tumor marker level. A partial response was defined as at least a 30% decrease in the sum of the longest diameter of target lesions, taking as reference the baseline sum of the longest diameter of target lesions., Baseline to the 21 July 2019 data cut-off (up to 7 years, 6 months)|Duration of Response, Duration of response was defined as the time from first occurrence of a documented confirmed objective response until the time of disease progression, as determined by investigator review of tumor assessments using Response Evaluation Criteria in Solid Tumors v1.1 or death from any cause during the study. Disease progression was defined as: (1) at least a 20% increase in the sum (the increase in the sum must be at least 5 mm) of diameters of target lesions, taking as reference the smallest sum during the study; (2) unequivocal progression of existing non-target lesions; or (3) the appearance of 1 or more new lesions., Baseline to the 21 July 2019 data cut-off (up to 7 years, 6 months)",,Hoffmann-La Roche,,ALL,"ADULT, OLDER_ADULT",PHASE3,495,INDUSTRY,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",GO28141|2012-003008-11,2013-01-08,2014-05-09,2019-07-21,2012-09-21,2015-10-30,2022-05-02,"University of Alabama at Birmingham, Birmingham, Alabama, 35233, United States|The Angeles Clinic and Research Institute - W LA Office, Los Angeles, California, 90025, United States|University of California Davis Health System, Sacramento, California, 95817, United States|Sutter Pacific Medical Foundation, Santa Rosa, California, 95403, United States|University Of Colorado, Aurora, Colorado, 80045, United States|Florida Cancer Specialists - Broadway, Fort Myers, Florida, 33901, United States|Mount Sinai Medical Center, Miami Beach, Florida, 33140, United States|Orlando Health Inc., Orlando, Florida, 32806, United States|Northwestern Center For Clinical Research, Chicago, Illinois, 60611, United States|Uni of Kansas Medical Center; Dept of Neurology, Kansas City, Kansas, 66160-7314, United States|U of L - Physicians Pulmonology; Dept of Neuroradiology and Dept of Diagnostic Radiology, Louisville, Kentucky, 40202, United States|Washington University School of Medicine; Dept of Medicine/Div of Medical Oncology, Saint Louis, Missouri, 63108, United States|Dartmouth-Hitchcock Medical Center; Department of Medicine, Lebanon, New Hampshire, 03756, United States|Novant Health Oncology Specialists, Winston-Salem, North Carolina, 27103, United States|University Hospitals of Cleveland, Cleveland, Ohio, 44106, United States|St. Luke's University Health network, Bethlehem, Pennsylvania, 18015, United States|Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, 19107, United States|University of Pittsburgh, Pittsburgh, Pennsylvania, 15261, United States|Rhode Island Hospital; Investigational Services, Providence, Rhode Island, 2903, United States|Vanderbilt University Medical Center, Nashville, Tennessee, 37232, United States|Chris O'Brien Lifehouse, Camperdown, New South Wales, 2050, Australia|Lake Macquarie Private Hospital, Gateshead, New South Wales, 2290, Australia|Lismore Base Hospital; Cancer Care & Haematology Unit, Lismore, New South Wales, 2480, Australia|Melanoma Institute Australia, North Sydney, New South Wales, 2060, Australia|Princess Alexandra Hospital, Woolloongabba, New South Wales, 2050, Australia|Royal Darwin Hospital, Casuarina, Northern Territory, 0811, Australia|Greenslopes Private Hospital, Greenslopes, Queensland, 4120, Australia|Royal Brisbane and Women's Hospital, Herston, Queensland, 4029, Australia|Royal Adelaide Hospital; Hepatology, Adelaide, South Australia, 5000, Australia|Ashford Cancer Centre, Ashford SA, South Australia, 5035, Australia|Royal Hobart Hospital, Hobart, Tasmania, 7000, Australia|Launceston General Hospital; Gastroenterology Research, Launceston, Tasmania, 7250, Australia|Peninsula and South Eastern Haematology and Oncology Group, Frankston, Victoria, 3199, Australia|Austin Hospital, Heidelberg, Victoria, 3084, Australia|Peter MacCallum Cancer Centre-East Melbourne, Melbourne, Victoria, 3000, Australia|The Alfred Hospital, Prahan, Victoria, 3181, Australia|Fiona Stanley Hospital, Murdoch, Western Australia, 6150, Australia|Ordensklinikum Linz Elisabethinen, Linz, 4020, Austria|Landesklinikum St. Pölten, St. Pölten, 3100, Austria|Medizinische Universität Wien, Wien, 1090, Austria|Institut Jules Bordet; Department of Medical Oncology, Bruxelles, 1000, Belgium|Cliniques Universitaires St-Luc, Bruxelles, 1200, Belgium|UZ Antwerpen, Edegem, 2650, Belgium|Jessa Zkh (Campus Virga Jesse), Hasselt, 3500, Belgium|CHU Sart-Tilman, Liège, 4000, Belgium|AZ Delta (Campus Rumbeke), Roeselare, 8800, Belgium|BC Cancer Agency Vancouver Island Cancer Centre, Victoria, British Columbia, V8R 6V5, Canada|Juravinski Cancer Clinic; Department of Oncology, Hamilton, Ontario, L8V 5C2, Canada|The Ottawa Hospital Cancer Center; General Campus, Ottawa, Ontario, K1H 1C4, Canada|Toronto Sunnybrook Hospital, Toronto, Ontario, M4N 3M5, Canada|Princess Margaret Hospital; Department of Med Oncology, Toronto, Ontario, M5G 2M9, Canada|London Health Sciences Centre · Victoria Hospital;Department of Pediatrics, London, Quebec, N6A 4G5, Canada|McGill University Health Centre/Glen Site / Royal Victoria Hospital, Montréal, Quebec, H2W 1S6, Canada|Masarykuv onkologicky ustav, Brno, 656 53, Czechia|Fakultni nemocnice Hradec Kralove, Hradec Kralove, 500 05, Czechia|Fakultní nemocnice Olomouc, Olomouc, 775 20, Czechia|Fakultni nemocnice Ostrava, Ostrava - Poruba, 708 52, Czechia|Multiscan s.r.o., Pardubice, 532 03, Czechia|Nemocnice Na Bulovce, Prague, 180 01, Czechia|Vseobecna fakultni nemocnice v Praze, Praha 2, 128 08, Czechia|Fakultni nemocnice Kralovske Vinohrady, Praha, 100 34, Czechia|Fakultni nemocnice Motol; Neurologicka klinika, Praha, 150 06, Czechia|Groupe Hospitalier Saint André - Hôpital Saint André, Bordeaux, 33075, France|Hôpital Ambroise Paré - Boulogne-Billancourt; Respiratory, Boulogne Billancourt, 92104, France|CHU Clermont Ferrand - Hôpital d'Estaing, Clermont Ferrand cedex 1, 63003, France|CHU de Dijon - Hopital le Bocage, Dijon, 21000, France|Centre Hospitalier Universitaire de Grenoble - Albert Michallon, La Tronche, 38700, France|Hopital Claude Huriez - CHU Lille, Lille, 59037, France|Hopital de la Timone, Marseille, 13005, France|Hopital Saint Eloi, Montpellier, 34295, France|CHU NANTES - Hôtel Dieu; Pharmacy, Nantes, 44093, France|CHU Nice - Hopital de l'Archet 2, Nice, 06202, France|Centre Hospitalier Lyon Sud, Pierre Benite, 69495, France|Hopital Robert Debre; DERMATOLOGIE, Reims, 51092, France|Centre Eugene Marquis; Service d'oncologie, Rennes, 35042, France|St. Josef-Hospital; Studienambulanz, Bochum, 44791, Germany|Elbekliniken Buxtehude GmbH, Buxtehude, 21614, Germany|Universitätsklinikum ""Carl Gustav Carus"" der Technischen Universität Dresden, Dresden, 01307, Germany|Helios Klinikum Erfurt, Erfurt, 99089, Germany|Universitätsklinikum Essen, Essen, 45147, Germany|Universitaetsklinikum Freiburg, Freiburg, 79106, Germany|SRH Wald-Klinikum Gera; Klinik für Hautkrankheiten und Allergologie, Gera, 07548, Germany|Universitätsmedizin Göttingen, Göttingen, 37075, Germany|Universitätsklinikum Hamburg-Eppendorf, Hamburg, 20246, Germany|Medizinische Hochschule Hannover, Hannover, 30625, Germany|Universitätsklinikum Heidelberg, Heidelberg, 69120, Germany|Universitaetsklinikum Schleswig-Holstein - Campus Kiel; Klinik fuer Allgemeine Innere Medizin, Kiel, 24105, Germany|Universitaetsklinikum Koeln; Hematology/Oncology, Koeln, 50937, Germany|Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz, Mainz, 55101, Germany|Klinikum Mannheim GmbH Universitätsklinikum, Mannheim, 68167, Germany|Fachklinik Hornheide, Muenster, 48157, Germany|Klinikum der Ludwigs-Maximilians-Universitaet Muenchen, München, 80337, Germany|Universitaetsklinikum Regensburg, Regensburg, 93053, Germany|Universitätsklinikum Tübingen, Tuebingen, 72076, Germany|Universitätsklinikum Wurzburg, Würzburg, 97080, Germany|Orszagos Onkologiai Intezet, Budapest, 1122, Hungary|Bekes Megyei Kozponti Korhaz Pandy Kalman Tagkorhaza, Gyula, 5700, Hungary|Somogy Megyei Kaposi Mor Oktato Korhaz, Pecs, 7624, Hungary|Szegedi Tud.Egyetem Szent-Gyorgyi Albert Klin.Kozp., Szeged, 6720, Hungary|Soroka Medical Center; Oncology Dept, Beer Sheva, 8410100, Israel|Rambam Health Care Campus, Haifa, 3109600, Israel|HADASSAH UNIVERSITY HOSPITAL, EIN KAREM; Oncology, Jerusalem, 9112000, Israel|Rabin Medical Center-Beilinson Campus;Hematology-Oncology, Petach Tikva, 4941492, Israel|Chaim Sheba Medical Center, Ramat Gan, 5265601, Israel|Tel Aviv Sourasky MC, Dana children's hospital;Oncology Division, Tel Aviv, 6423906, Israel|Istituto Nazionale Tumori Fondazione G. Pascale, Napoli, Campania, 80131, Italy|Istituto Scientifico Romagnolo Per Lo Studio e La Cura Dei Tumori, Meldola, Emilia-Romagna, 47014, Italy|A.O.U. Policlinico di Modena, Modena, Emilia-Romagna, 40124, Italy|Istituto Nazionale Tumori Regina Elena IRCCS, Roma, Lazio, 00144, Italy|Istituto Nazionale per la Ricerca sul Cancro di Genova, Genova, Liguria, 16132, Italy|Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII (Presidio Papa Giovanni XXIII), Bergamo, Lombardia, 24127, Italy|Asst Degli Spedali Civili Di Brescia, Brescia, Lombardia, 25100, Italy|Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Lombardia, 20133, Italy|Istituto Tumori Giovanni Paolo II IRCSS; Ospedale Oncologico Bari, Bari, Puglia, 70126, Italy|A.O.U. Senese Policlinico Santa Maria Alle Scotte, Siena, Toscana, 53100, Italy|IOV - Istituto Oncologico Veneto IRCCS, Padova, Veneto, 35128, Italy|Amsterdam UMC Location VUMC, Amsterdam, 1081 HV, Netherlands|Leids Universitair Medisch Centrum; Cardiology, Leiden, 2333 ZA, Netherlands|Maastricht University Medical Center, Maastricht, 6229 HX, Netherlands|Auckland City Hospital, Auckland, 1023, New Zealand|Waikato Hospital, Hamilton, 3248, New Zealand|Radiumhospitalet, Oslo, 0379, Norway|TSBHI Altai Territorial oncological dispensary, Barnaul, 656045, Russian Federation|FSBSI ""N. N. Blokhin Russian Cancer Research Center"", Moscow, 115478, Russian Federation|Moscow city oncology hospital #62 of Moscow Healthcare Department, Moscow, 143423, Russian Federation|BHI of Omsk region Clinical Oncology Dispensary, Omsk, 644013, Russian Federation|Pyatigorsky Oncologic Dispensary, Pyatigorsk, 357524, Russian Federation|Complexo Hospitalario Universitario de Santiago, Santiago de Compostela, LA Coruña, 15706, Spain|Clinica Universitaria de Navarra, Pamplona, Navarra, 31008, Spain|Hospital Universitario Virgen Macarena, Seville, Sevilla, 41071, Spain|Hospital Clínic i Provincial de Barcelona, Barcelona, 08036, Spain|MD Anderson Cancer Center, Madrid, 28033, Spain|Hospital Universitario 12 de Octubre, Madrid, 28041, Spain|Hospital General Universitario de Valencia, Valencia, 46014, Spain|Hospital Universitario Miguel Servet, Zaragoza, 50009, Spain|Länssjukhuset Ryhov, Jönköping, 551 85, Sweden|Skånes Universitetssjukhus, Lund, 221 85, Sweden|Sahlgrenska Sjukhuset, Mölnlycke, 435 33, Sweden|Akademiska Sjukhuset, Uppsala, 751 85, Sweden|Inselspital-Universitaetsspital Bern, Bern, 3010, Switzerland|Kantonsspital Graubuenden, Chur, 7000, Switzerland|Bristol Haematology and Oncology Centre, Bristol, BS2 8ED, United Kingdom|Addenbrooke's Hospital, Cambridge, CB2 0QQ, United Kingdom|Velindre Cancer Centre, Cardiff, CF14 2TL, United Kingdom|Western General Hospital, Edinburgh, EH4 2XU, United Kingdom|Beatson West of Scotland Cancer Centre, Glasgow, G12 0YN, United Kingdom|The Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool, L7 8YA, United Kingdom|Barts and the London NHS Trust., London, EC1A 7BE, United Kingdom|St George's Hospital; Courtyard Clinic, London, SW17 0QT, United Kingdom|Royal Marsden Hospital - Fulham, London, SW3 6JJ, United Kingdom|Royal Marsden Hospital - London, London, SW3 6JJ, United Kingdom|Freeman Hospital, Newcastle upon Tyne, NE7 7DN, United Kingdom|Nottingham University Hospitals; QMC Campus, Nottingham, NG7 2UH, United Kingdom|Southampton General Hospital, Southampton, SO16 6YD, United Kingdom|Royal Cornwall Hospital, Truro, TR1 3LQ, United Kingdom|New Cross Hospital, Wolverhampton, WV10 0QP, United Kingdom","Study Protocol, https://cdn.clinicaltrials.gov/large-docs/19/NCT01689519/Prot_001.pdf"
